Opinion: Biosimilars could disappear if the Supreme Court overturns the ACA
With the sense of urgency rightly focused on slowing or stopping the spread of Covid-19, it seems like everything else in the news, and in health care, has come to a grinding halt. Yet important decision-making continues in the background, including some that could have long-lasting effects on health care today and in the future.
One of these is the decision by the U.S. Supreme Court to hear California v. Texas, a case that will decide whether most or all of the Affordable Care Act should be overturned.
Read Original Article: Opinion: Biosimilars could disappear if the Supreme Court overturns the ACA »
